Cohance Lifesciences Limited — Important, 09-05-2025: General Updates

Cohance Lifesciences has completed its merger with Cohance Lifesciences Limited, issuing 12.8 crore shares to the transferor’s shareholders at an exchange ratio of 11 for every 295 shares held. Shares will be listed on BSE and NSE. The company has officially changed its name to Cohance Lifesciences Limited following the merger, signaling a strategic consolidation aimed at streamlining operations under a unified brand.